6[1]Boumpas DT, Austin III HA, Vaughan EM, et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med, 1993; 119(5):366
7[2]Blow JE, Boumpas DT, Fessler BJ, et al. Management of lupus nephritis. Kidney International, 1996; 49(Suppl 53):88
8[3]Out HJ, Groot PGD, Hasselaar P, et al. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. AnnRheum Dis, 1989; 48(12):1023
9[4]Chapman RM, Sutcliffe SB. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood, 1981; 58(4):849
10[5]Montz FJ, Wolff AJ, Gambone JC. Gonadal protection and fecundity rates in cyclophosphamide-treated rats. Cancer Research, 1991; 51(8):2124
5Tobias Lahmer,Uwe Heemann.Anti-glomerular basement membrane antibody disease: A rare autoimmune disorder affecting the kidney and the lung[J].Autoimmunity Reviews.2012(2)
6Heng Li,Xiangdong Shi,Hong Shen,Xiayu Li,Huiping Wang,Hongmei Li,Guangbiao Xu,Jianghua Chen.Tacrolimus Versus Intravenous Pulse Cyclophosphamide Therapy in Chinese Adults With Steroid-Resistant Idiopathic Minimal Change Nephropathy: A Multicenter, Open-Label, Nonrandomized Cohort Trial[J].Clinical Therapeutics.2012(5)
7Frédéric A.Houssiau,CarlosVasconcelos,DavidD’Cruz,Gian DomenicoSebastiani,Enrique de RamonGarrido,Maria GiovannaDanieli,DanielAbramovicz,DanielBlockmans,AlessandroMathieu,HanerDireskeneli,MauroGaleazzi,AhmetGül,YairLevy,PeterPetera,RajkoPopovic,RadmilaPetrovic,Renato AlbertoSinico,RobertoCattaneo,JosepFont,GenevièveDepresseux,Jean‐PierreCosyns,RicardCervera.Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide[J].Arthritis & Rheumatism.2002(8)
8Chi ChiuMok,Carmen Tze KwanHo,Kwok WahChan,Chak SingLau,Raymond Woon SingWong.Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine[J].Arthritis & Rheumatism.2002(4)
9Colleoni M, Orlando L, Sanna G,et al. Metronomic low-dose oral cy-clophosphamide and methotrexate plus or minus thalidomide in met-gotatic bregot cancer: Antitumor activity and biological effects [ J].Ann Oncol,2006,17(2) :232.238.
10Korkmaz A,Oter S,Deveci S,et al. Involvement of nitric oxide andhyperbaric oxygen in the pathogenesis of cyclophosphamide inducedhemorrhagic cystitis in rats[ J]. J Urol,2003 ,170 ( 6 pt 1 ) :2498-2502.
